Oncology & Cancer

Drug shows promise for subset of stage III colon cancer patients

A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological ...

page 35 from 40